Cardiac-specific downregulation of YAP inhibits cardiac hypertrophy but promotes heart failure during acute PO, indicating that endogenous YAP is salutary and mediates compensatory hypertrophy during acute PO (3). This evidence concerns the gene YAP1 and cardiac hypertrophy.